$PSID “We brought these highly regarded industry experts on board to help accelerate value creation at ExcitePCR,” stated Lyle L. Probst, CEO, President and Founder of ExcitePCR. “We believe that utilizing their relevant experience, insights and relationships enhances our ability to execute on our plans to complete the development of FireflyDX™ and achieve exponential growth for our company and our shareholders.”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.